Middle East Pharmaceutical Industries Company (TADAWUL:4016)

Saudi Arabia flag Saudi Arabia · Delayed Price · Currency is SAR
117.90
+0.40 (0.34%)
Jul 23, 2025, 3:19 PM AST
0.34%
Market Cap2.36B
Revenue (ttm)415.54M
Net Income (ttm)89.88M
Shares Out20.00M
EPS (ttm)4.49
PE Ratio26.30
Forward PE24.45
Dividend2.50 (2.13%)
Ex-Dividend DateMay 4, 2025
Volume15,122
Average Volume22,754
Open117.60
Previous Close117.50
Day's Range117.10 - 118.60
52-Week Range107.00 - 144.60
Betan/a
RSI39.75
Earnings DateAug 12, 2025

About TADAWUL:4016

Middle East Pharmaceutical Industries Company engages in the research, development, manufacture, and marketing of generic medicines and pharmaceutical preparations in the Kingdom of Saudi Arabia and internationally. The company operates through three segments: Private, Public, and Export. It offers medicines and preparations used to treat skin diseases, skin creams, and skin care products; respiratory, central nervous, digestive, and musculoskeletal system medicines; urinary and reproductive system drugs; disinfectants; and various therapeutic ... [Read more]

Industry Medical - Pharmaceuticals
Sector Healthcare
Founded 1998
Employees 632
Stock Exchange Saudi Stock Exchange
Ticker Symbol 4016
Full Company Profile

Financial Performance

In 2024, TADAWUL:4016's revenue was 394.00 million, an increase of 16.42% compared to the previous year's 338.44 million. Earnings were 79.85 million, an increase of 21.30%.

Financial Statements

News

There is no news available yet.